CeriBell, Inc

CeriBell reported a study showing that higher AI-detected seizure burden is linked to increased odds of disability at discharge. The study, published in Critical Care Medicine, analyzed 359 adult patients across three academic centers and found that patients with a peak seizure burden of at least 90% were 3.4 times more likely to experience death or severe disability compared to those with no seizure burden. Each additional hour of AI-detected seizure activity nearly doubled the odds of severe disability or death, with an adjusted odds ratio of 1.98. Lead author Josef Parvizi said the algorithm detects clinically relevant biomarkers with prognosis, underlining potential for earlier intervention, while CEO Jane Chao noted that continuous monitoring allows live assessment and more informed clinical decisions.